已收录 268921 条政策
 政策提纲
  • 暂无提纲
Does Quinolone- or Macrolide-Resistant Streptococcus agalactiae Bacteremia Affect Patient Outcome? A Multicenter Cohort Study
[摘要] The prevalence of quinolone- and macrolide-resistant Group B Streptococcus (GBS) is increasing worldwide, but the relationship between the resistance of GBS to these antibiotics and patient outcome remains unclear. Therefore, we evaluated whether blood stream infection caused by quinolone- or macrolide-resistant GBS is associated with high mortality. Our findings in 77 patients with GBS bacteremia demonstrate that quinolone and macrolide resistance may not be risk factors for 30-day mortality.
[发布日期]  [发布机构] 
[效力级别]  [学科分类] 传染病学
[关键词]  [时效性] 
   浏览次数:2      统一登录查看全文      激活码登录查看全文